NAARDEN, Netherlands, & MUNICH–(BUSINESS WIRE)–Forbion, a leading European life science venture capital firm, today announces that it has led a €17m Series C financing of OMEICOS Therapeutics GmbH, a privately held biopharmaceutical company based in Berlin, Germany. Forbion is the only new investor participating in the financing round, contributing €12.5m […]